gp120 antibody
gp120 Antibody |
|||
8677-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
8677-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
4641-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
4641-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
4777-002mg | ProSci | 0.02 mg | 206.18 EUR |
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
4777-01mg | ProSci | 0.1 mg | 523.7 EUR |
Description: gp120 Antibody: Human immunodeficiency virus type 1 (HIV-1) entry into target cells is directed by the envelope (Env) glycoproteins, which are present on the surface of HIV-1 virion or infected cells in the form of trimers consisting of gp120/gp41 complexes. The surface subunit, gp120, initiates the entry process by interacting sequentially with the CD4 receptor and a co-receptor CCR5 or CXCR4, thereby inducing a conformational change that allows the transmembrane (TM) gp41 subunit to mediate fusion between viral and target cell membranes. Cleavage of Env into its gp120 and gp41 components is necessary for activation of its fusogenic activity. |
|||
gp120 Antibody |
|||
24700 | SAB | 100ul | 479 EUR |
gp120 Antibody |
|||
24745 | SAB | 100ul | 479 EUR |
HIV1 gp120 antibody |
|||
10-2771 | Fitzgerald | 100 ug | 404.4 EUR |
Description: Monoclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
10-H30M | Fitzgerald | 100 ug | 333.6 EUR |
Description: Mouse monoclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20R-2834 | Fitzgerald | 100 ul | 975.6 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20C-CR2102RP | Fitzgerald | 100 ug | 826.8 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20-000401 | Fitzgerald | 500 ul | 812.4 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20-000401F | Fitzgerald | 500 ul | 492 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20-000402 | Fitzgerald | 100 ug | 210 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20-HG81 | Fitzgerald | 1 mg | 376.8 EUR |
Description: Goat polyclonal HIV1 gp120 antibody |
|||
HIV1 gp120 antibody |
|||
20-000402F | Fitzgerald | 100 ug | 135 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody |
|||
HIV-1 gp120 Antibody |
|||
20-abx137103 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
20-abx137183 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
20-abx137505 | Abbexa |
|
|
HIV-1 gp120 Antibody |
|||
abx023024-1ml | Abbexa | 1 ml | 777.6 EUR |
HIV1 gp120 antibody (HRP) |
|||
61-001002 | Fitzgerald | 50 ug | 159.6 EUR |
Description: Mouse monoclonal HIV1 gp120 antibody (HRP) |
|||
HIV1 gp120 antibody (HRP) |
|||
60-H14 | Fitzgerald | 1 ml | 490.8 EUR |
Description: Goat polyclonal HIV1 gp120 antibody (HRP) conjugated |
|||
HIV1 gp120 antibody (FITC) |
|||
60-00402-3 | Fitzgerald | 50 ug | 201.6 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody (FITC) conjugated |
|||
SIV mac251 gp120 antibody |
|||
20-000111 | Fitzgerald | 500 ul | 476.4 EUR |
Description: Rabbit polyclonal SIV mac251 gp120 antibody |
|||
SIV mac251 gp120 antibody |
|||
20-000112 | Fitzgerald | 100 ug | 386.4 EUR |
Description: Rabbit polyclonal SIV mac251 gp120 antibody |
|||
SIV macC251 gp120 antibody |
|||
10R-S109a | Fitzgerald | 100 ug | 716.4 EUR |
Description: Mouse monoclonal SIV macC251, gp120 antibody |
|||
HIV1 gp120 antibody (biotin) |
|||
61-001005 | Fitzgerald | 50 ug | 483.6 EUR |
Description: Mouse monoclonal HIV1 gp120 protein (biotin) |
|||
HIV1 gp120 antibody (biotin) |
|||
60-00402-5 | Fitzgerald | 50 ug | 543.6 EUR |
Description: Rabbit polyclonal HIV1 gp120 antibody (biotin) conjugated |
|||
HIV1 gp120 antibody (biotin) |
|||
60C-CR1248GB | Fitzgerald | 1 ml | 544.8 EUR |
Description: Goat polyclonal HIV1 gp120 antibody (biotin) conjugated |
|||
HIV-1 gp120 Antibody (HRP) |
|||
abx023023-1ml | Abbexa | 1 ml | 794.4 EUR |
HIV-1 gp120 Antibody (Biotin) |
|||
abx023022-1ml | Abbexa | 1 ml | 718.8 EUR |
SIV mac251 gp120 antibody (FITC) |
|||
60-00112-3 | Fitzgerald | 50 ug | 159.6 EUR |
Description: Rabbit polyclonal SIV mac251 gp120 antibody (FITC) |
|||
SIV mac251 gp120 antibody (biotin) |
|||
60-00112-5 | Fitzgerald | 50 ug | 489.6 EUR |
Description: Rabbit polyclonal SIV gp 120 antibody (biotin) |
|||
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
|||
abx412175-1mg | Abbexa | 1 mg | 610.8 EUR |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody |
|||
abx411417-1ml | Abbexa | 1 ml | 610.8 EUR |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody (HRP) |
|||
abx411419-1ml | Abbexa | 1 ml | 760.8 EUR |
Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 (HIV1 gp120) Antibody (Biotin) |
|||
abx411418-1ml | Abbexa | 1 ml | 710.4 EUR |
HIV-1 gp120 mouse monoclonal antibody, clone CB-gp120, Purified |
|||
AM32228PU-N | Origene Technologies GmbH | 100 µg | Ask for price |
Mouse antibody for HIV-1 gp120 |
|||
1996 | Virostat | 100 ug | 425.4 EUR |
Description: This is purified Mouse monoclonal antibody against HIV-1 gp120 for WB, ELISA. |
|||
OAPA00052-500UG - HIV-1 gp120 Antibody |
|||
OAPA00052-500UG | Aviva Systems Biology | 500ug | 308 EUR |
Mouse anti HIVgp160, gp120, gp41 Monoclonal Antibody |
|||
TA354788 | Origene Technologies GmbH | 100 µg | Ask for price |
Mouse anti HIVgp160, gp120, gp41 Monoclonal Antibody |
|||
TA354789 | Origene Technologies GmbH | 100 µg | Ask for price |
HIV-1 gp120 goat polyclonal antibody, HRP |
|||
BP1035HRP | Origene Technologies GmbH | 1 ml | Ask for price |
OASA06275-1ML - HIV1 gp120 Antibody - HRP Conjugated |
|||
OASA06275-1ML | Aviva Systems Biology | 1ml | 499 EUR |
Goat Anti-HIV-1 gp120 Polyclonal Antibody |
|||
DPAB0252 | Creative Diagnostics | 1 ml | 889.2 EUR |
Goat Anti-HIV-1 gp120 Polyclonal Antibody |
|||
DPAB0253 | Creative Diagnostics | 1 ml | 937.2 EUR |
Goat Anti-HIV-1 gp120 Polyclonal Antibody |
|||
DPAB0254 | Creative Diagnostics | 1 ml | 999.6 EUR |
OASA06274-1ML - HIV1 gp120 Antibody - Biotin Conjugated |
|||
OASA06274-1ML | Aviva Systems Biology | 1ml | 479 EUR |
HIV-1 gp120 goat polyclonal antibody, Biotin |
|||
BP1035B | Origene Technologies GmbH | 1 ml | Ask for price |
HIV-1 gp120 goat polyclonal antibody, Ig Fraction |
|||
BP1035 | Origene Technologies GmbH | 1 ml | Ask for price |
HIV-1 (gp120/160) mouse monoclonal antibody, clone 114D3.08 |
|||
DDX1300P-100 | Origene Technologies GmbH | 100 µg | Ask for price |
HIV-1 (gp120/160) mouse monoclonal antibody, clone 113B4.07 |
|||
DDX1301B-100 | Origene Technologies GmbH | 100 µg | Ask for price |
HIV-1 (gp120/160) mouse monoclonal antibody, clone 113B4.07 |
|||
DDX1301P-100 | Origene Technologies GmbH | 100 µg | Ask for price |
HIV-1 (gp120/160) mouse monoclonal antibody, clone 109A2.01 |
|||
DDX1303A647-100 | Origene Technologies GmbH | 100 µg | Ask for price |
HIV-1 (gp120/160) mouse monoclonal antibody, clone 109A2.01 |
|||
DDX1303B-100 | Origene Technologies GmbH | 100 µg | Ask for price |
HIV-1 (gp120/160) mouse monoclonal antibody, clone 109A2.01 |
|||
DDX1303P-100 | Origene Technologies GmbH | 100 µg | Ask for price |
HIV-1 (gp120/160) mouse monoclonal antibody, clone 115F10.05 |
|||
DDX1302B-100 | Origene Technologies GmbH | 100 µg | Ask for price |
HIV-1 (gp120/160) mouse monoclonal antibody, clone 115F10.05 |
|||
DDX1302P-100 | Origene Technologies GmbH | 100 µg | Ask for price |
gp120 Peptide |
|||
8677P | ProSci | 0.05 mg | 197.7 EUR |
Description: gp120 Peptide |